MedTrace Logo

Lipid Profile as Predictor of Adverse Maternal and Neonatal Outcomes: A Pilot Study

NCT05535660 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 111

Last updated 2024-11-07

No results posted yet for this study

Summary

The purpose of this study is to ascertain lipid profiles during pregnancy, specifically during the 24-28 week gestation and again near term at 36 weeks gestation. The research team are investigating whether lipid profiles can predict adverse maternal and neonatal outcomes.

Conditions

Interventions

DIAGNOSTIC_TEST

Lipid panel

fasting blood draw to examine concentrations of lipids in maternal blood during pregnancy

Sponsors & Collaborators

Principal Investigators

  • Samsiya Ona, MD · Icahn School of Medicine at Mount Sinai

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-29
Primary Completion
2024-08-05
Completion
2024-08-05

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05535660 on ClinicalTrials.gov